A new study from the Community Oncology Alliance (COA) shows that patients treated in community oncology settings—like St. Louis Cancer Care—may experience longer survival compared to national benchmarks. Researchers analyzed data from nearly 98,000 patients with metastatic breast cancer and metastatic non-small cell lung cancer and compared outcomes to the National Cancer Institute’s SEER database. The results were encouraging. Patients with metastatic breast cancer lived up

Dr. Giancarlo Pillot recently attended the Community Oncology Alliance (COA) Conference, joining oncology leaders from across the country to discuss the latest advancements in cancer care. The annual COA conference focuses on innovation in practice, advocacy for community oncology, and strategies to improve patient outcomes close to home. At St. Louis Cancer Care, we are committed to staying at the forefront of oncology care. By engaging with national organizations like COA,

If you or a loved one has been diagnosed with cancer, you may hear your care team mention “genetic testing.” For many patients, this can feel confusing or even overwhelming. What does it mean? Why is it important? And how does it affect your treatment? Let’s break it down in a simple, practical way. What is genetic testing in cancer? Genetic testing looks at the DNA involved in cancer to help guide treatment decisions. There are two main types of genetic testing, and understa

St. Louis Cancer Care is proud to announce that Dr. Giancarlo Pillot has been appointed to the Board of Directors for Athena Oncology . Athena Oncology is a national organization that brings together independent oncology practices across the country to collaborate on clinical research, share best practices, and strengthen access to high-quality cancer care in community settings. Through this collaboration, member practices work together to expand clinical trial opportunities

Understanding Bile Duct Cancer and the Progress Bringing New Hope February is an important time to raise awareness about cholangiocarcinoma , also known as bile duct cancer . While it is considered a rare cancer, its incidence has been rising worldwide and for many families, it arrives unexpectedly and feels overwhelming. The encouraging news? The last five to ten years have brought remarkable progress . Today, treatment is more personalized, more targeted, and more hopeful t

Cancer care is expensive. As treatments become more complex, with immunotherapies, targeted agents, diagnostics, supportive care, and...

June is a month of celebration for many reasons, but for us at St. Louis Cancer Care, it holds a special place in our hearts as Cancer...

At St. Louis Cancer Care, we're committed to integrating cutting-edge research into our treatment plans, ensuring our patients receive...

As an oncologist at St. Louis Cancer Center, I’m excited to share with our patients and their families an emerging and promising area of...